Vaccine dose gap increased in India on the advice of UK, now Britain has announced to reduce the gap in its own country

In Britain, it has been announced to reduce the gap in the dosage of Coronavirus Vaccine. Prime Minister Boris Johnson said on Friday that people above 50 years of age and clinically vulnerable people in Britain would be given the vaccine dose as soon as possible. PM Johnson told reporters that the second dose would be given in only eight weeks instead of 12 weeks. It is worth noting here that the dose gap was increased in India only on the advice of Britain and WHO. In such a situation, questions are now being raised on the decision of Britain.

The BBC quoted PM Johnson as saying, the B.1.1.7 variant of the corona found in India has been found to be more infectious and spreading rapidly. He said that because of this we may have to take some strict steps. The PM said that the plan to end the lockdown completely on June 21 may be hampered due to this variant. Significantly, after rapidly applying the vaccine in Britain, the government has relaxed the lockdown. Since then, Britons are slowly moving towards normal life. The government plans to remove the lockdown completely from the country by June 21.

UK-WHO recommends a gap of 4 to 12 weeks and 8 to 12 weeks

At the same time, in India, the gap of 6 to 8 weeks between the first and second doses of the Covishield vaccine has been increased to 12 to 16 weeks. It is believed that this has been done on the advice of Britain and the World Health Organization (WHO). The UK and WHO recommend a gap of 4 to 12 weeks and 8 to 12 weeks respectively between the two doses. On the other hand, on 30 April Spain revised its national guidelines regarding the vaccine. Spain said that people over the age of 60 who have received the first dose should take the second dose at an interval of 12 to 16 weeks.

Vaccine 81.3% effective when administered after 12 weeks

Experts from the Oxford Vaccine Group analyzed the results of four trials on 17,178 participants from Britain, Brazil and South Africa. After this, an article published in the Lancet regarding these results said that the Oxford-AstraZeneca vaccine is 55.1 percent effective when its two doses are administered in less than six weeks. At the same time, its efficacy becomes 81.3 percent when applied after more than 12 weeks.

Health Ministry of India widens the gap between doses

The European Union has approved a 4- to 12-week gap between the first and second doses of the Oxford-AstraZeneca vaccine. At the same time, the Ministry of Health of India approved the advice of NTAGI’s Kovid Working Group to increase the gap between the two doses. This approval has been given for the Kovidshield vaccine. This decision was taken by the ministry when there are reports of vaccine shortage in many states. Due to this, people without vaccination, including those who got the first dose, are facing problems.

read this also: Was Corona born from Wuhan’s lab itself? Scientist said – the answer to this question will save from future danger

Related Articles